Calcaneal SpurNCT06510673
Effect of Extracorporeal Shockwave Therapy, High Power-LASER & Platelet-rich Protein on Pain and Function in Patients With Calcaneal Spur A Randomized Comparative Study.
A study testing Platelet rich plasma, High power LASER and Shockwave therapy in people with Calcaneal Spur, run by Cairo University at 1 site in Egypt.
Trial summary
PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application… Read more about this study
- Who is it for?
- Ages 25 to 40 years
- Conditions the study is for
- Calcaneal Spur
- What is being tested?
- Platelet rich plasma, High power LASER and Shockwave therapy
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 96 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Oct 2024to 1 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- diagnosed with calcaneal spur based on clinical examination and radiological findings.
Who cannot join
- were as follows: acute trauma to the foot, history of fracture or surgery, lower extremity neurological deficit, polyneuropathy, radicular pain, autoimmune diseases tumor, thrombosis, soft tissue or bone infection, or skin disorder.
Trial locations and contacts
1 site in 1 country.
About this study
PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application, platelet-rich plasma therapy (PRP), shoe modification, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT), laser therapy (LLLT) are commonly used in the treatment of calcaneal spur.
HYPOTHESES: There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on pain intensity in patients with calcaneal spur There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on function in patients with calcaneal spur. There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on the size of calcaneal spur in patients with calcaneal spur.
RESEARCH QUESTION: Is there any difference between the effect of Extracorporeal shock wave therapy and High-power LASER on calcaneal spur?
- Conditions
- Calcaneal Spur
- Being tested
- Platelet rich plasma, High power LASER, Shockwave therapy, Sham LASER
- Medical subject headings
- Heel Spur
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Platelet rich plasmaDrug
Platelet-rich plasma for the heel
High power LASEROther
High power LASER sessions for the heel
Shockwave therapyOther
Shockwave therapy sessions for the heel
Sham LASEROther
Sham LASER for the heel
| Study group | Role | What they receive |
|---|---|---|
| Shockwave therapy | Experimental | Shockwave therapy for calcaneal spur Receives: Other: Shockwave therapy |
| High-power LASER therapy | Experimental | High-power LASER therapy for calcaneal spur Receives: Other: High power LASER |
| Control | Sham comparator | cold application with receive 6 sessions of sham LASER therapy. Receives: Other: Sham LASER |
| Platelet rich plasma | Experimental | Platelet-rich plasma injection for the heel Receives: Drug: Platelet rich plasma |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Visual Analog Scale
It is a self reported outcome which is a 10 cm line with zero at one end indicating no pain and 10 at the other end indicating maximum pain. Patient will be asked to mark the current pain on the scale and the distance from the starting point (0) will be measured
Measured: Baseline and after one month
foot function index.
measure the impact of foot pathology on function in terms of pain, disability and activity restriction. it is a self-administered index
Measured: Baseline and after one month
calcaneal Spur length
Spur length will be measured by MRI
Measured: Baseline and after one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jul 2024
- Study start1 Oct 2024
- Primary completion1 Apr 2025
- Study completion1 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Calcaneal SpurStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 96 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Collaborators
- Suez University, Badr University, Helwan University
- Responsible party
- Principal investigator, Mina Magdy Wahba, Suez University
- Investigators
- Doaa Elsayed, Study chair, Department of Physical therapy for Woman's Health, Faculty of Physical Therapy, Badr University in Cairo, Cairo, EgyptDoha Hamed, Study chair, Basic Sciences Department, Faculty of Physical Therapy, Badr University in CairoAhmed Zakaria, Study chair, Department of orthopedic surgery, Helwan UniversityOmnya Samy, Study director, Department of Physical Therapy for Pediatrics and Pediatric Surgery, Faculty of Physical Therapy, Badr University in CairoFatma Zidan, Study director, Department of Physical therapy for Neuromuscular Disorders & its Surgery, Faculty of Physical Therapy, Badr University in CairoDoaa Saeed, Study chair, Department of Physical Therapy for Women's Health, Faculty of Physical Therapy, Badr University in Cairo, Cairo, Egypt
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06510673
- Sponsor's protocol ID
- SU1
- Status last verified
- Aug 2024
- First submitted
- 15 Jul 2024
- Last updated
- 12 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Extracorporeal Shockwave Therapy, High Power-LASER & Platelet-rich Protein on Pain and Function in Patients With Calcaneal Spur A Randomized Comparative Study.
- ClinicalTrials.gov ID
- NCT06510673
- Acronym / sponsor ID
- SU1
- Conditions
- Calcaneal Spur
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 96 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Collaborators
- Suez University, Badr University, Helwan University
- Study start
- 1 Oct 2024 (actual)
- Primary completion
- 1 Apr 2025 (actual)
- Study completion
- 1 Jun 2025 (actual)
- First posted
- 19 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application, platelet-rich plasma therapy (PRP), shoe modification, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT), laser therapy (LLLT) are commonly used in the treatment of calcaneal spur.
HYPOTHESES: There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on pain intensity in patients with calcaneal spur There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on function in patients with calcaneal spur. There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on the size of calcaneal spur in patients with calcaneal spur.
RESEARCH QUESTION: Is there any difference between the effect of Extracorporeal shock wave therapy and High-power LASER on calcaneal spur?
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Shockwave therapy | Experimental | Other: Shockwave therapyShockwave therapy for calcaneal spur |
| High-power LASER therapy | Experimental | Other: High power LASERHigh-power LASER therapy for calcaneal spur |
| Control | Sham comparator | Other: Sham LASERcold application with receive 6 sessions of sham LASER therapy. |
| Platelet rich plasma | Experimental | Drug: Platelet rich plasmaPlatelet-rich plasma injection for the heel |
Who may qualify
- Ages
- 25 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- diagnosed with calcaneal spur based on clinical examination and radiological findings.
Key exclusion criteria (1 listed)
- were as follows: acute trauma to the foot, history of fracture or surgery, lower extremity neurological deficit, polyneuropathy, radicular pain, autoimmune diseases tumor, thrombosis, soft tissue or bone infection, or skin disorder.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Platelet rich plasmaPlatelet-rich plasma for the heel | Drug | Platelet rich plasma |
| High power LASERHigh power LASER sessions for the heel | Other | High-power LASER therapy |
| Shockwave therapyShockwave therapy sessions for the heel | Other | Shockwave therapy |
| Sham LASERSham LASER for the heel | Other | Control |
Primary outcome
Pain Visual Analog Scale
Time frame: Baseline and after one month
It is a self reported outcome which is a 10 cm line with zero at one end indicating no pain and 10 at the other end indicating maximum pain. Patient will be asked to mark the current pain on the scale and the distance from the starting point (0) will be measured
foot function index.
Time frame: Baseline and after one month
measure the impact of foot pathology on function in terms of pain, disability and activity restriction. it is a self-administered index
calcaneal Spur length
Time frame: Baseline and after one month
Spur length will be measured by MRI
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Calcaneal Spur
Recruiting
Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs
Calcaneal Spur
RecruitingObservational study
Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT in Heel Spur With Plantar Fasciitis
Calcaneal Spur
Not yet recruitingObservational study
Evaluation Of Balance And Ankle Proprioception In Calcaneal Spur Patients
Calcaneal Spur
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Doaa Elsayed study chair
Department of Physical therapy for Woman's Health, Faculty of Physical Therapy, Badr University in Cairo, Cairo, Egypt
Doha Hamed study chair
Basic Sciences Department, Faculty of Physical Therapy, Badr University in Cairo
Ahmed Zakaria study chair
Department of orthopedic surgery, Helwan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Platelet rich plasma, High power LASER and Shockwave therapy in people with Calcaneal Spur, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Visual Analog Scale (time frame: Baseline and after one month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026; AzTrials last refreshed its copy on 7 Nov 2026.